Listing of Color Additives Exempt From Certification; Astaxanthin Dimethyldisuccinate, 57248-57251 [E9-26524]
Download as PDF
57248
Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Rules and Regulations
IV. Environmental Analysis
10. The Commission is required to
prepare an Environmental Assessment
or an Environmental Impact Statement
for any action that may have a
significant adverse effect on the quality
of the human environment.4 Issuance of
this Final Rule does not represent a
major Federal action having a
significant adverse effect on the quality
of the human environment under the
Commission’s regulations implementing
the National Environmental Policy Act.
Part 380 of the Commission’s
regulations lists exemptions to the
requirement to draft an Environmental
Analysis or Environmental Impact
Statement. Included is an exemption for
procedural, ministerial or internal
administrative actions.5 This
rulemaking is exempt under that
provision.
V. Regulatory Flexibility Act
11. The Regulatory Flexibility Act of
1980 (RFA) 6 generally requires a
description and analysis of final rules
that will have significant economic
impact on a substantial number of small
entities. This Final Rule concerns
matters of internal agency procedure.
The Commission therefore certifies that
it will not have such an impact. An
analysis under the RFA is not required.
erowe on DSK5CLS3C1PROD with RULES
VI. Document Availability
12. In addition to publishing the full
text of this document in the Federal
Register, the Commission provides all
interested persons an opportunity to
view and/or print the contents of this
document via the Internet through
FERC’s Home Page (https://www.ferc.gov)
and in FERC’s Public Reference Room
during normal business hours (8:30 a.m.
to 5 p.m. Eastern time) at 888 First
Street, NE., Room 2A, Washington, DC
20426.
13. From FERC’s Home Page on the
Internet, this information is available on
eLibrary. The full text of this document
is available on eLibrary in PDF and
Microsoft Word format for viewing,
printing, and/or downloading. To access
this document in eLibrary, type the
docket number excluding the last three
digits of this document in the docket
number field.
14. User assistance is available for
eLibrary and the FERC’s Web site during
normal business hours from FERC
Online Support at 202–502–6652 (toll
4 Regulations
Implementing the National
Environmental Policy Act of 1969, Order No. 486,
52 FR 47897 (Dec. 17, 1987), FERC Stats. & Regs.
¶ 30,783 (1987).
5 18 CFR 380.4(1) and (5).
6 5 U.S.C. 601–612.
VerDate Nov<24>2008
14:36 Nov 04, 2009
Jkt 220001
free at 1–866–208–3676) or e-mail at
ferconlinesupport@ferc.gov, or the
Public Reference Room at (202) 502–
8371, TTY (202) 502–8659. E-mail the
Public Reference Room at
public.referenceroom@ferc.gov.
VII. Effective Date and Congressional
Notification
15. These regulations are effective
immediately upon publication in the
Federal Register. In accordance with 5
U.S.C. 553(d)(3), the Commission finds
that good cause exists to make this Final
Rule effective immediately. It makes
minor revisions to matters of internal
operations and is unlikely to affect the
rights of persons appearing before the
Commission. There is therefore no
reason to make this rule effective at a
later time.
16. The provisions of 5 U.S.C. 801
regarding Congressional review of Final
Rules do not apply to this Final Rule,
because this Final Rule concerns agency
procedure and practice and will not
substantially affect the rights of nonagency parties.
17. The Commission is issuing this as
a Final Rule without a period for public
comment. Under 5 U.S.C. 553(b), notice
and comment procedures are
unnecessary where a rulemaking
concerns only agency procedure and
practice, or where the agency finds that
notice and comment is unnecessary.
This rule concerns only matters of
internal agency procedure and will not
significantly affect regulated entities or
the general public.
List of Subjects in 18 CFR Part 375
Authority delegations (Government
agencies), Seals and insignia, Sunshine
Act.
By the Commission.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
PART 375—THE COMMISSION
1. The authority citation for Part 375
continues to read as follows:
■
Authority: 5 U.S.C. 551–557; 15 U.S.C.
717–717w, 3301–3432; 16 U.S.C. 791–825r,
2601–2645; 42 U.S.C. 7101–7352, 16451–
16463.
2. Section 375.302 is amended by
adding paragraph (aa) as follows:
■
Delegations to the Secretary.
*
*
*
*
*
(aa) Issue a notice that the
Commission will not further review on
PO 00000
Frm 00006
Fmt 4700
3. Section 375.311 is amended by
adding paragraphs (u) and (v) as
follows:
■
§ 375.311 Delegations to the Director of
the Office of Enforcement.
*
*
*
*
*
(u) Direct the Electric Reliability
Organization or the applicable Regional
Entity to provide such information as is
necessary to implement Section
215(e)(2) of the Federal Power Act (16
U.S.C. 824o(e)(2)) pursuant to § 39.2 and
Part 40 of this chapter.
(v) Issue an order extending the
period of time for consideration of a
Notice of Penalty filed under Section
215(e) of the Federal Power Act for the
purpose of directing the Electric
Reliability Organization or the
applicable Regional Entity to provide
such information as is necessary to
implement Section 215(e)(2) of the
Federal Power Act (16 U.S.C. 824o(e)(2))
pursuant to § 39.2 and Part 40 of this
chapter.
[FR Doc. E9–26635 Filed 11–4–09; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 73
[Docket No. FDA–2007–C–0044] (formerly
Docket No. 2007C–0474)
Listing of Color Additives Exempt
From Certification; Astaxanthin
Dimethyldisuccinate
AGENCY:
In consideration of the foregoing, the
Commission amends Part 375, Chapter I,
Title 18, Code of Federal Regulations, as
follows.
■
§ 375.302
its own motion a Notice of Penalty filed
under Section 215(e) of the Federal
Power Act.
Sfmt 4700
Food and Drug Administration,
HHS.
ACTION:
Final rule.
SUMMARY: The Food and Drug
Administration (FDA) is amending the
color additive regulations to provide for
the safe use of astaxanthin
dimethyldisuccinate as a color additive
in the feed of salmonid fish to enhance
the color of their flesh. This action is in
response to a petition filed by DSM
Nutritional Products, Inc.
DATES: This rule is effective December 8,
2009, except as to any provisions that
may be stayed by the filing of proper
objections. Submit electronic or written
objections and requests for a hearing by
December 7, 2009. See section X of this
document for information on the filing
of objections.
E:\FR\FM\05NOR1.SGM
05NOR1
Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Rules and Regulations
You may submit electronic
or written objections and requests for a
hearing, identified by Docket No. FDA–
2007–C–0044, by any of the following
methods:
ADDRESSES:
Electronic Submissions
Submit electronic objections in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
erowe on DSK5CLS3C1PROD with RULES
Written Submissions
Submit written objections in the
following ways:
• Fax: 301–827–6870.
• Mail/Hand delivery/Courier [For
paper, disk, or CD–ROM submissions]:
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
To ensure more timely processing of
objections, FDA is no longer accepting
objections submitted to the agency by email. FDA encourages you to continue
to submit electronic objections by using
the Federal eRulemaking Portal, as
described previously in the ADDRESSES
portion of this document under
Electronic Submissions.
Instructions: All submissions received
must include the agency name and
Docket No. for this rulemaking. All
objections received will be posted
without change to https://www.
regulations.gov, including any personal
information provided. For detailed
instructions on submitting objections,
see the ‘‘Objections’’ heading of the
SUPPLEMENTARY INFORMATION section of
this document.
Docket: For access to the docket to
read background documents or
objections received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Felicia M. Ellison, Center for Food
Safety and Applied Nutrition (HFS–
265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 301–436–1264.
SUPPLEMENTARY INFORMATION:
I. Background
In a notice published in the Federal
Register of December 4, 2007 (72 FR
68166), with a correction of the docket
number on December 26, 2007 (72 FR
73028), FDA announced that a color
additive petition (CAP 7C0284) had
been filed by DSM Nutritional Products,
VerDate Nov<24>2008
14:36 Nov 04, 2009
Jkt 220001
Inc., 45 Waterview Blvd., Parsippany,
NJ 07054. The petition proposed to
amend the color additive regulations in
part 73 (21 CFR part 73) to provide for
the safe use of astaxanthin
dimethyldisuccinate (hereinafter
referred to as astaxanthin DMDS) as a
color additive in the feed of salmonid
fish to enhance the color of their flesh.
II. Identity, Technical Effect, and
Specifications
Astaxanthin DMDS (3,3′-bis(4methoxy-1,4-dioxobutoxy)-b,b-carotene4,4′-dione) is a synthetic carotenoid
with pink or red pigmenting properties.
Astaxanthin DMDS is derived by
esterification of astaxanthin, the
principal pigment that imparts the
characteristic pink or orange-red
coloring of the flesh of wild salmonids,
followed by several purification steps.
The color additive contains not less
than 96 percent astaxanthin DMDS,
including trans, 9-cis, and 13-cis
isomers, and minor amounts of
astaxanthin monomethylsuccinate
(MMS) and free astaxanthin. Other
carotenoids (present at not more than 4
percent) are the esters of astaxanthinrelated substances.
The stability studies of astaxanthin
DMDS submitted by the petitioner show
that astaxanthin DMDS is unstable on
its own. Therefore, in order to minimize
chemical changes that would result in
loss of color of astaxanthin, astaxanthin
DMDS may be added to fish feed only
in the form of a stabilized color additive
mixture. This requirement is reflected in
new § 73.37(a)(2), which provides that
astaxanthin DMDS be added to fish feed
only as a component of a stabilized
color additive mixture.
In the Federal Register of April 13,
1995 (60 FR 18736), the agency
published a final rule that listed
astaxanthin in § 73.35 for use in the feed
of salmonid fish. In that final rule, the
agency concluded that 80 milligrams
(mg) of astaxanthin per (/) kilogram (kg)
of finished feed would result in
adequate pigmentation of the flesh of
salmonids. Therefore, in § 73.35(c)(2),
the agency limited the astaxanthin
content of finished feed to not more
than 80 mg/kg. In the Federal Register
of July 6, 2000 (65 FR 41581 and 41584),
the agency published final rules that
listed haematococcus algae meal
(§ 73.185) and phaffia yeast (§ 73.355) as
additional sources of astaxanthin for use
in the feed of salmonid fish. Both
haematococcus algae meal and phaffia
yeast may be used alone or in
combination with other astaxanthin
color additive sources, provided that the
quantity of astaxanthin in the finished
feed does not exceed 80 mg/kg.
PO 00000
Frm 00007
Fmt 4700
Sfmt 4700
57249
Consistent with these other listings,
the petitioner proposes that the
maximum amount of astaxanthin in
finished feed from the use of
astaxanthin DMDS not exceed 110 mg/
kg, which corresponds to an astaxanthin
equivalent of 80 mg/kg (72 grams (g) per
ton) in the finished feed. Because of the
other listed sources of astaxanthin and
other color additives that are sources of
astaxanthin the agency may list in the
future, new § 73.37(c)(2) requires that
the quantity of astaxanthin in finished
feed, from astaxanthin DMDS when
used alone or in combination with other
astaxanthin color additive sources listed
in part 73, shall not exceed 80 mg/kg (72
g per ton) of finished feed.
III. Evaluation of Safety
Data provided by the petitioner
demonstrate that the color additive is
safe for the fish at the proposed use
levels, and that astaxanthin DMDS is
converted to free astaxanthin during
digestion and deposited as such in the
flesh of the fish. There also is no
evidence that any constituents of the
color additive, other than astaxanthin,
will accumulate in fish maintained on
diets supplemented with astaxanthin
DMDS. Consequently, consumers will
not be directly exposed to astaxanthin
DMDS, but to the astaxanthin in the
flesh of the fish that have consumed the
color additive. The safety of astaxanthin
has been previously established (see 65
FR 41581 and 41584).
FDA has determined that the
astaxanthin from the subject color
additive will substitute for the fish feed
uses of other approved color additive
sources of astaxanthin. Additionally, the
agency considers the intake of
astaxanthin from the consumption of
wild salmon and the intake of
astaxanthin from consumption of farmraised salmonid fish that have been fed
approved color additive sources of
astaxanthin to be comparable.
Therefore, the agency concludes that the
petitioned use of the subject color
additive will not increase the current
cumulative estimated daily intake of
astaxanthin. Based on this information,
as well as other relevant material
provided by the petitioner, FDA
concludes that the petitioned use of
astaxanthin DMDS is safe.
IV. Labeling Requirements
All color additives, in accordance
with § 70.25 (21 CFR 70.25), are
required to be labeled with sufficient
information to assure their safe use and
to allow a determination of compliance
with any limitations imposed by the
agency in other applicable regulations.
The labeling of the color additive,
E:\FR\FM\05NOR1.SGM
05NOR1
erowe on DSK5CLS3C1PROD with RULES
57250
Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Rules and Regulations
astaxanthin DMDS, and any mixture
prepared therefrom, is subject to the
requirements of § 70.25.
According to § 70.25(a)(4), an
expiration date for a color additive must
be stated on its label if stability data
require it. FDA finds that because of the
instability of astaxanthin DMDS,
expiration dates must be stated on the
label of the sealed and open containers,
in accordance with § 70.25(a)(4). FDA
also finds that declaration of the
expiration dates constitutes a material
fact that must be disclosed on the label
of the stabilized mixture formulated
with astaxanthin DMDS because under
sections 201(n) and 403(a)(1) of the
Federal Food, Drug, and Cosmetic Act
(the act) (21 U.S.C. 321(n) and
343(a)(1)), failure to do so would
constitute a failure to reveal facts
material in light of the representations
made on the label and material with
respect to consequences which may
result from the use of the color additive.
The use of astaxanthin DMDS requires
the declaration of expiration dates
because the astaxanthin component of
astaxanthin DMDS is unstable and can
decompose, thereby affecting the
efficacy of the color.
In addition to the requirements for
labeling the color additive or color
additive mixture, the ingredient list on
fish feed to which astaxanthin DMDS is
added must identify the presence of the
color additive under § 501.4 (21 CFR
501.4). New § 73.37(d)(2) references
§ 501.4 to ensure that the presence of
astaxanthin DMDS as a color additive in
the fish feed will be declared on the
ingredient label. Finally, the presence of
the color additive must be declared on
the label of any food, including
salmonid fish given feed containing
astaxanthin DMDS and food containing
such salmonid fish as an ingredient.
Section 101.22(b) (21 CFR 101.22(b))
requires a food that bears or contains
artificial coloring, such as salmon
artificially colored with a source of
astaxanthin, to bear labeling even
though such food is not in package
form. Section 101.22(c) requires that
label statements of artificial coloring be
‘‘likely to be read by the ordinary person
under customary conditions of purchase
and use of such food.’’
Furthermore, § 101.22(k)(2) requires,
in the statement of ingredients for a food
to which any coloring has been added,
and for which the coloring is not subject
to certification, a declaration that makes
it clear that a color additive has been
used in the food. In addition, the
presence of a color additive in a food
received in a bulk container that is held
at a retail establishment must be
declared on the labeling of the bulk
VerDate Nov<24>2008
14:36 Nov 04, 2009
Jkt 220001
container or on a counter card or other
similar device under the provisions in
§ 101.100(a)(2) (21 CFR 101.100(a)(2)).
The ingredient label would alert the
consumer that the fish is artificially
colored. Without such ingredient
labeling, food containing salmonid fish
previously given feed containing
astaxanthin DMDS would be deemed to
be misbranded under section 403(k) of
the act, which states that a food shall be
deemed to be misbranded ‘‘if it bears or
contains any artificial flavoring,
artificial coloring, or chemical
preservative, unless it bears labeling
stating that fact.’’
Therefore, in accordance with
§§ 101.22(b), (c), and (k)(2), and
101.100(a)(2), labeling on any salmonid
fish given feed containing astaxanthin
DMDS is required to declare the
presence of the color additive. New
§ 73.37(d)(3) references §§ 101.22(b), (c),
and (k)(2), and 101.100(a)(2) to ensure
that, at the retail level, the presence of
a source of astaxanthin as a color
additive in the fish will be declared, and
that the labeling of the bulk fish
container, including a list of
ingredients, will be displayed on the
container or on a counter card with
similar information.
V. Conclusion
FDA reviewed data in the petition and
other available relevant material to
evaluate the safety of the use of
astaxanthin DMDS as a color additive in
the feed of salmonid fish to enhance the
color of their flesh. Based on this
information, the agency concludes that
the proposed use of the additive is safe
and the additive will achieve its
intended technical effect. Therefore, the
regulations in part 73 should be
amended as set forth in this document.
In addition, based upon the factors
listed in 21 CFR 71.20(b), the agency
concludes that certification of
astaxanthin DMDS is not necessary for
the protection of the public health.
VI. Public Disclosure
In accordance with § 71.15 (21 CFR
71.15), the petition and the documents
that FDA considered and relied upon in
reaching its decision to approve the
petition will be made available for
inspection at the Center for Food Safety
and Applied Nutrition by appointment
with the information contact person
listed above (see FOR FURTHER
INFORMATION CONTACT). As provided in
§ 71.15, the agency will delete from the
documents any materials that are not
available for public disclosure before
making the documents available for
inspection.
PO 00000
Frm 00008
Fmt 4700
Sfmt 4700
VII. Environmental Impact
The agency has previously considered
the environmental effects of this rule as
announced in the notice of filing for
CAP 7C0284 (72 FR 68166 and 72 FR
73028). No new information or
comments have been received that
would affect the agency’s previous
determination that there is no
significant impact on the human
environment and that an environmental
impact statement is not required.
VIII. Paperwork Reduction Act of 1995
This final rule contains no collection
of information. Therefore, clearance by
the Office of Management and Budget
under the Paperwork Reduction Act of
1995 (44 U.S.C. 3501–3520) is not
required.
IX. Section 301(ll) of the Federal Food,
Drug, and Cosmetic Act
FDA’s review of this petition was
limited to section 721 of the act (21
U.S.C. 379e). This final rule is not a
statement regarding compliance with
other sections of the act. For example,
the Food and Drug Administration
Amendments Act of 2007, which was
signed into law on September 27, 2007,
amended the act to, among other things,
add section 301(ll). Section 301(ll) of
the act (21 U.S.C. 331(ll)) prohibits the
introduction or delivery for introduction
into interstate commerce of any food
that contains a drug approved under
section 505 of the act (21 U.S.C. 355),
a biological product licensed under
section 351 of the Public Health Service
Act (42 U.S.C. 262), or a drug or
biological product for which substantial
clinical investigations have been
instituted and their existence has been
made public, unless one of the
exemptions in section 301(ll)(1)–(4)
applies. In our review of this petition,
FDA did not consider whether section
301(ll) of the act or any of its
exemptions apply to food products
containing this color additive.
Accordingly, this final rule should not
be construed to be a statement that a
product containing this color additive, if
introduced or delivered for introduction
into interstate commerce, would not
violate section 301(ll) of the act.
Furthermore, this language is included
in all color additive final rules that
pertain to food and therefore should not
be construed to be a statement of the
likelihood that section 301(ll) of the act
applies.
X. Objections
This rule is effective as shown in the
DATES section of this document, except
as to any provisions that may be stayed
by the filing of proper objections. Any
E:\FR\FM\05NOR1.SGM
05NOR1
Federal Register / Vol. 74, No. 213 / Thursday, November 5, 2009 / Rules and Regulations
person who will be adversely affected
by this regulation may at any time file
with the Division of Dockets
Management (see ADDRESSES) electronic
or written objections. Each objection
shall be separately numbered, and each
numbered objection shall specify with
particularity the provisions of the
regulation to which objection is made
and the grounds for the objection. Each
numbered objection on which a hearing
is requested shall specifically so state.
Failure to request a hearing for any
particular objection shall constitute a
waiver of the right to a hearing on that
objection. Each numbered objection for
which a hearing is requested shall
include a detailed description and
analysis of the specific factual
information intended to be presented in
support of the objection in the event
that a hearing is held. Failure to include
such a description and analysis for any
particular objection shall constitute a
waiver of the right to a hearing on the
objection. Three copies of all documents
are to be submitted and are to be
identified with the docket number
found in brackets in the heading of this
document. Any objections received in
response to the regulation may be seen
in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday. FDA will publish notice
of the objections that the agency has
received or lack thereof in the Federal
Register.
List of Subjects in 21 CFR Part 73
Color additives, Cosmetics, Drugs,
Foods, Medical devices.
■ Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs, and redelegated to
the Director, Center for Food Safety and
Applied Nutrition, 21 CFR part 73 is
amended as follows:
PART 73—LISTING OF COLOR
ADDITIVES EXEMPT FROM
CERTIFICATION
1. The authority citation for 21 CFR
part 73 continues to read as follows:
■
Authority: 21 U.S.C. 321, 341, 342, 343,
348, 351, 352, 355, 361, 362, 371, 379e.
2. Section 73.37 is added to subpart A
to read as follows:
■
erowe on DSK5CLS3C1PROD with RULES
§ 73.37
Astaxanthin dimethyldisuccinate.
(a) Identity. (1) The color additive
astaxanthin dimethyldisuccinate is 3,3′bis(4-methoxy-1,4-dioxobutoxy)-b,bcarotene–4,4′-dione.
(2) Astaxanthin dimethyldisuccinate
may be added to the fish feed only as
a component of a stabilized mixture.
Color additive mixtures for fish feed use
VerDate Nov<24>2008
14:36 Nov 04, 2009
Jkt 220001
made with astaxanthin
dimethyldisuccinate may contain only
those diluents that are suitable and are
listed in this subpart as safe for use in
color additive mixtures for coloring
foods.
(b) Specifications. Astaxanthin
dimethyldisuccinate shall conform to
the following specifications and shall be
free from impurities other than those
named to the extent that such impurities
may be avoided by good manufacturing
practice:
(1) Physical state, solid.
(2) 0.05 percent solution in
chloroform, complete and clear.
(3) Absorption maximum wavelength
484–493 nanometers (in chloroform).
(4) Residue on ignition, not more than
0.1 percent.
(5) Total carotenoids other than
astaxanthin dimethyldisuccinate, not
more than 4 percent.
(6) Lead, not more than 5 milligrams
per kilogram (mg/kg) (5 parts per
million).
(7) Arsenic, not more than 2 mg/kg (2
parts per million).
(8) Mercury, not more than 1 mg/kg (1
part per million).
(9) Heavy metals, not more than 10
mg/kg (10 parts per million).
(10) Assay including astaxanthin
dimethyldisuccinate, astaxanthin
monomethylsuccinate, and astaxanthin,
minimum 96 percent.
(c) Uses and restrictions. Astaxanthin
dimethyldisuccinate may be safely used
in the feed of salmonid fish in
accordance with the following
prescribed conditions:
(1) The color additive is used to
enhance the pink to orange-red color of
the flesh of salmonid fish.
(2) The quantity of astaxanthin
dimethyldisuccinate in the finished
feed, when used alone or in
combination with other astaxanthin
color additive sources listed in this part
73, shall not exceed 110 milligrams per
kilogram (mg/kg), which is equivalent to
80 mg/kg astaxanthin (72 grams per
ton).
(d) Labeling requirements. (1) The
labeling of the color additive and any
premixes prepared therefrom shall bear
expiration dates for the sealed and open
container (established through generally
accepted stability testing methods),
other information required by § 70.25 of
this chapter, and adequate directions to
prepare a final product complying with
the limitations prescribed in paragraph
(c) of this section.
(2) The presence of the color additive
in finished fish feed prepared according
to paragraph (c) of this section shall be
declared in accordance with § 501.4 of
this chapter.
PO 00000
Frm 00009
Fmt 4700
Sfmt 4700
57251
(3) The presence of the color additive
in salmonid fish that have been fed
feeds containing astaxanthin
dimethyldisuccinate shall be declared
in accordance with §§ 101.22(b), (c), and
(k)(2), and 101.100(a)(2) of this chapter.
(e) Exemption from certification.
Certification of this color additive is not
necessary for the protection of the
public health, and therefore batches
thereof are exempt from the certification
requirements of section 721(c) of the act.
Dated: October 21, 2009.
Leslye M. Fraser,
Director, Office of Regulations, Policy and
Social Sciences, Center for Food Safety and
Applied Nutrition.
[FR Doc. E9–26524 Filed 11–04–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF THE TREASURY
Internal Revenue Service
26 CFR Part 1
[TD 9465]
RIN 1545–BF71
Determination of Interest Expense
Deduction of Foreign Corporations;
Correction
AGENCY: Internal Revenue Service (IRS),
Treasury.
ACTION: Correcting amendments.
SUMMARY: This document contains
corrections to final regulations (TD
9465) that were published in the
Federal Register on Monday, September
28, 2009 (74 FR 49315) concerning the
determination of the interest expense
deduction of foreign corporations
engaged in a trade or business within
the United States. These final
regulations conform the interest expense
rules to recent U.S. Income Tax Treaty
agreements and adopt other changes to
improve compliance.
DATES: This correction is effective on
November 5, 2009], and is applicable on
September 28, 2009.
FOR FURTHER INFORMATION CONTACT:
Anthony J. Marra, (202) 622–3870 (not
a toll-free number).
SUPPLEMENTARY INFORMATION:
Background
The final regulations (TD 9465) that
are the subject of this document are
under sections 882 and 884 of the
Internal Revenue Code.
Need for Correction
As published, the final regulations
(TD 9465) contain errors that may prove
E:\FR\FM\05NOR1.SGM
05NOR1
Agencies
[Federal Register Volume 74, Number 213 (Thursday, November 5, 2009)]
[Rules and Regulations]
[Pages 57248-57251]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-26524]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 73
[Docket No. FDA-2007-C-0044] (formerly Docket No. 2007C-0474)
Listing of Color Additives Exempt From Certification; Astaxanthin
Dimethyldisuccinate
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the color
additive regulations to provide for the safe use of astaxanthin
dimethyldisuccinate as a color additive in the feed of salmonid fish to
enhance the color of their flesh. This action is in response to a
petition filed by DSM Nutritional Products, Inc.
DATES: This rule is effective December 8, 2009, except as to any
provisions that may be stayed by the filing of proper objections.
Submit electronic or written objections and requests for a hearing by
December 7, 2009. See section X of this document for information on the
filing of objections.
[[Page 57249]]
ADDRESSES: You may submit electronic or written objections and requests
for a hearing, identified by Docket No. FDA-2007-C-0044, by any of the
following methods:
Electronic Submissions
Submit electronic objections in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Written Submissions
Submit written objections in the following ways:
Fax: 301-827-6870.
Mail/Hand delivery/Courier [For paper, disk, or CD-ROM
submissions]: Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
To ensure more timely processing of objections, FDA is no longer
accepting objections submitted to the agency by e-mail. FDA encourages
you to continue to submit electronic objections by using the Federal
eRulemaking Portal, as described previously in the ADDRESSES portion of
this document under Electronic Submissions.
Instructions: All submissions received must include the agency name
and Docket No. for this rulemaking. All objections received will be
posted without change to https://www.regulations.gov, including any
personal information provided. For detailed instructions on submitting
objections, see the ``Objections'' heading of the SUPPLEMENTARY
INFORMATION section of this document.
Docket: For access to the docket to read background documents or
objections received, go to https://www.regulations.gov and insert the
docket number, found in brackets in the heading of this document, into
the ``Search'' box and follow the prompts and/or go to the Division of
Dockets Management, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Felicia M. Ellison, Center for Food
Safety and Applied Nutrition (HFS-265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-1264.
SUPPLEMENTARY INFORMATION:
I. Background
In a notice published in the Federal Register of December 4, 2007
(72 FR 68166), with a correction of the docket number on December 26,
2007 (72 FR 73028), FDA announced that a color additive petition (CAP
7C0284) had been filed by DSM Nutritional Products, Inc., 45 Waterview
Blvd., Parsippany, NJ 07054. The petition proposed to amend the color
additive regulations in part 73 (21 CFR part 73) to provide for the
safe use of astaxanthin dimethyldisuccinate (hereinafter referred to as
astaxanthin DMDS) as a color additive in the feed of salmonid fish to
enhance the color of their flesh.
II. Identity, Technical Effect, and Specifications
Astaxanthin DMDS (3,3'-bis(4-methoxy-1,4-dioxobutoxy)-[bgr],[bgr]-
carotene-4,4'-dione) is a synthetic carotenoid with pink or red
pigmenting properties. Astaxanthin DMDS is derived by esterification of
astaxanthin, the principal pigment that imparts the characteristic pink
or orange-red coloring of the flesh of wild salmonids, followed by
several purification steps. The color additive contains not less than
96 percent astaxanthin DMDS, including trans, 9-cis, and 13-cis
isomers, and minor amounts of astaxanthin monomethylsuccinate (MMS) and
free astaxanthin. Other carotenoids (present at not more than 4
percent) are the esters of astaxanthin-related substances.
The stability studies of astaxanthin DMDS submitted by the
petitioner show that astaxanthin DMDS is unstable on its own.
Therefore, in order to minimize chemical changes that would result in
loss of color of astaxanthin, astaxanthin DMDS may be added to fish
feed only in the form of a stabilized color additive mixture. This
requirement is reflected in new Sec. 73.37(a)(2), which provides that
astaxanthin DMDS be added to fish feed only as a component of a
stabilized color additive mixture.
In the Federal Register of April 13, 1995 (60 FR 18736), the agency
published a final rule that listed astaxanthin in Sec. 73.35 for use
in the feed of salmonid fish. In that final rule, the agency concluded
that 80 milligrams (mg) of astaxanthin per (/) kilogram (kg) of
finished feed would result in adequate pigmentation of the flesh of
salmonids. Therefore, in Sec. 73.35(c)(2), the agency limited the
astaxanthin content of finished feed to not more than 80 mg/kg. In the
Federal Register of July 6, 2000 (65 FR 41581 and 41584), the agency
published final rules that listed haematococcus algae meal (Sec.
73.185) and phaffia yeast (Sec. 73.355) as additional sources of
astaxanthin for use in the feed of salmonid fish. Both haematococcus
algae meal and phaffia yeast may be used alone or in combination with
other astaxanthin color additive sources, provided that the quantity of
astaxanthin in the finished feed does not exceed 80 mg/kg.
Consistent with these other listings, the petitioner proposes that
the maximum amount of astaxanthin in finished feed from the use of
astaxanthin DMDS not exceed 110 mg/kg, which corresponds to an
astaxanthin equivalent of 80 mg/kg (72 grams (g) per ton) in the
finished feed. Because of the other listed sources of astaxanthin and
other color additives that are sources of astaxanthin the agency may
list in the future, new Sec. 73.37(c)(2) requires that the quantity of
astaxanthin in finished feed, from astaxanthin DMDS when used alone or
in combination with other astaxanthin color additive sources listed in
part 73, shall not exceed 80 mg/kg (72 g per ton) of finished feed.
III. Evaluation of Safety
Data provided by the petitioner demonstrate that the color additive
is safe for the fish at the proposed use levels, and that astaxanthin
DMDS is converted to free astaxanthin during digestion and deposited as
such in the flesh of the fish. There also is no evidence that any
constituents of the color additive, other than astaxanthin, will
accumulate in fish maintained on diets supplemented with astaxanthin
DMDS. Consequently, consumers will not be directly exposed to
astaxanthin DMDS, but to the astaxanthin in the flesh of the fish that
have consumed the color additive. The safety of astaxanthin has been
previously established (see 65 FR 41581 and 41584).
FDA has determined that the astaxanthin from the subject color
additive will substitute for the fish feed uses of other approved color
additive sources of astaxanthin. Additionally, the agency considers the
intake of astaxanthin from the consumption of wild salmon and the
intake of astaxanthin from consumption of farm-raised salmonid fish
that have been fed approved color additive sources of astaxanthin to be
comparable. Therefore, the agency concludes that the petitioned use of
the subject color additive will not increase the current cumulative
estimated daily intake of astaxanthin. Based on this information, as
well as other relevant material provided by the petitioner, FDA
concludes that the petitioned use of astaxanthin DMDS is safe.
IV. Labeling Requirements
All color additives, in accordance with Sec. 70.25 (21 CFR 70.25),
are required to be labeled with sufficient information to assure their
safe use and to allow a determination of compliance with any
limitations imposed by the agency in other applicable regulations. The
labeling of the color additive,
[[Page 57250]]
astaxanthin DMDS, and any mixture prepared therefrom, is subject to the
requirements of Sec. 70.25.
According to Sec. 70.25(a)(4), an expiration date for a color
additive must be stated on its label if stability data require it. FDA
finds that because of the instability of astaxanthin DMDS, expiration
dates must be stated on the label of the sealed and open containers, in
accordance with Sec. 70.25(a)(4). FDA also finds that declaration of
the expiration dates constitutes a material fact that must be disclosed
on the label of the stabilized mixture formulated with astaxanthin DMDS
because under sections 201(n) and 403(a)(1) of the Federal Food, Drug,
and Cosmetic Act (the act) (21 U.S.C. 321(n) and 343(a)(1)), failure to
do so would constitute a failure to reveal facts material in light of
the representations made on the label and material with respect to
consequences which may result from the use of the color additive. The
use of astaxanthin DMDS requires the declaration of expiration dates
because the astaxanthin component of astaxanthin DMDS is unstable and
can decompose, thereby affecting the efficacy of the color.
In addition to the requirements for labeling the color additive or
color additive mixture, the ingredient list on fish feed to which
astaxanthin DMDS is added must identify the presence of the color
additive under Sec. 501.4 (21 CFR 501.4). New Sec. 73.37(d)(2)
references Sec. 501.4 to ensure that the presence of astaxanthin DMDS
as a color additive in the fish feed will be declared on the ingredient
label. Finally, the presence of the color additive must be declared on
the label of any food, including salmonid fish given feed containing
astaxanthin DMDS and food containing such salmonid fish as an
ingredient. Section 101.22(b) (21 CFR 101.22(b)) requires a food that
bears or contains artificial coloring, such as salmon artificially
colored with a source of astaxanthin, to bear labeling even though such
food is not in package form. Section 101.22(c) requires that label
statements of artificial coloring be ``likely to be read by the
ordinary person under customary conditions of purchase and use of such
food.''
Furthermore, Sec. 101.22(k)(2) requires, in the statement of
ingredients for a food to which any coloring has been added, and for
which the coloring is not subject to certification, a declaration that
makes it clear that a color additive has been used in the food. In
addition, the presence of a color additive in a food received in a bulk
container that is held at a retail establishment must be declared on
the labeling of the bulk container or on a counter card or other
similar device under the provisions in Sec. 101.100(a)(2) (21 CFR
101.100(a)(2)). The ingredient label would alert the consumer that the
fish is artificially colored. Without such ingredient labeling, food
containing salmonid fish previously given feed containing astaxanthin
DMDS would be deemed to be misbranded under section 403(k) of the act,
which states that a food shall be deemed to be misbranded ``if it bears
or contains any artificial flavoring, artificial coloring, or chemical
preservative, unless it bears labeling stating that fact.''
Therefore, in accordance with Sec. Sec. 101.22(b), (c), and
(k)(2), and 101.100(a)(2), labeling on any salmonid fish given feed
containing astaxanthin DMDS is required to declare the presence of the
color additive. New Sec. 73.37(d)(3) references Sec. Sec. 101.22(b),
(c), and (k)(2), and 101.100(a)(2) to ensure that, at the retail level,
the presence of a source of astaxanthin as a color additive in the fish
will be declared, and that the labeling of the bulk fish container,
including a list of ingredients, will be displayed on the container or
on a counter card with similar information.
V. Conclusion
FDA reviewed data in the petition and other available relevant
material to evaluate the safety of the use of astaxanthin DMDS as a
color additive in the feed of salmonid fish to enhance the color of
their flesh. Based on this information, the agency concludes that the
proposed use of the additive is safe and the additive will achieve its
intended technical effect. Therefore, the regulations in part 73 should
be amended as set forth in this document. In addition, based upon the
factors listed in 21 CFR 71.20(b), the agency concludes that
certification of astaxanthin DMDS is not necessary for the protection
of the public health.
VI. Public Disclosure
In accordance with Sec. 71.15 (21 CFR 71.15), the petition and the
documents that FDA considered and relied upon in reaching its decision
to approve the petition will be made available for inspection at the
Center for Food Safety and Applied Nutrition by appointment with the
information contact person listed above (see FOR FURTHER INFORMATION
CONTACT). As provided in Sec. 71.15, the agency will delete from the
documents any materials that are not available for public disclosure
before making the documents available for inspection.
VII. Environmental Impact
The agency has previously considered the environmental effects of
this rule as announced in the notice of filing for CAP 7C0284 (72 FR
68166 and 72 FR 73028). No new information or comments have been
received that would affect the agency's previous determination that
there is no significant impact on the human environment and that an
environmental impact statement is not required.
VIII. Paperwork Reduction Act of 1995
This final rule contains no collection of information. Therefore,
clearance by the Office of Management and Budget under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501-3520) is not required.
IX. Section 301(ll) of the Federal Food, Drug, and Cosmetic Act
FDA's review of this petition was limited to section 721 of the act
(21 U.S.C. 379e). This final rule is not a statement regarding
compliance with other sections of the act. For example, the Food and
Drug Administration Amendments Act of 2007, which was signed into law
on September 27, 2007, amended the act to, among other things, add
section 301(ll). Section 301(ll) of the act (21 U.S.C. 331(ll))
prohibits the introduction or delivery for introduction into interstate
commerce of any food that contains a drug approved under section 505 of
the act (21 U.S.C. 355), a biological product licensed under section
351 of the Public Health Service Act (42 U.S.C. 262), or a drug or
biological product for which substantial clinical investigations have
been instituted and their existence has been made public, unless one of
the exemptions in section 301(ll)(1)-(4) applies. In our review of this
petition, FDA did not consider whether section 301(ll) of the act or
any of its exemptions apply to food products containing this color
additive. Accordingly, this final rule should not be construed to be a
statement that a product containing this color additive, if introduced
or delivered for introduction into interstate commerce, would not
violate section 301(ll) of the act. Furthermore, this language is
included in all color additive final rules that pertain to food and
therefore should not be construed to be a statement of the likelihood
that section 301(ll) of the act applies.
X. Objections
This rule is effective as shown in the DATES section of this
document, except as to any provisions that may be stayed by the filing
of proper objections. Any
[[Page 57251]]
person who will be adversely affected by this regulation may at any
time file with the Division of Dockets Management (see ADDRESSES)
electronic or written objections. Each objection shall be separately
numbered, and each numbered objection shall specify with particularity
the provisions of the regulation to which objection is made and the
grounds for the objection. Each numbered objection on which a hearing
is requested shall specifically so state. Failure to request a hearing
for any particular objection shall constitute a waiver of the right to
a hearing on that objection. Each numbered objection for which a
hearing is requested shall include a detailed description and analysis
of the specific factual information intended to be presented in support
of the objection in the event that a hearing is held. Failure to
include such a description and analysis for any particular objection
shall constitute a waiver of the right to a hearing on the objection.
Three copies of all documents are to be submitted and are to be
identified with the docket number found in brackets in the heading of
this document. Any objections received in response to the regulation
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday. FDA will publish notice of the objections
that the agency has received or lack thereof in the Federal Register.
List of Subjects in 21 CFR Part 73
Color additives, Cosmetics, Drugs, Foods, Medical devices.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, and
redelegated to the Director, Center for Food Safety and Applied
Nutrition, 21 CFR part 73 is amended as follows:
PART 73--LISTING OF COLOR ADDITIVES EXEMPT FROM CERTIFICATION
0
1. The authority citation for 21 CFR part 73 continues to read as
follows:
Authority: 21 U.S.C. 321, 341, 342, 343, 348, 351, 352, 355,
361, 362, 371, 379e.
0
2. Section 73.37 is added to subpart A to read as follows:
Sec. 73.37 Astaxanthin dimethyldisuccinate.
(a) Identity. (1) The color additive astaxanthin
dimethyldisuccinate is 3,3'-bis(4-methoxy-1,4-dioxobutoxy)-[bgr],[bgr]-
carotene-4,4'-dione.
(2) Astaxanthin dimethyldisuccinate may be added to the fish feed
only as a component of a stabilized mixture. Color additive mixtures
for fish feed use made with astaxanthin dimethyldisuccinate may contain
only those diluents that are suitable and are listed in this subpart as
safe for use in color additive mixtures for coloring foods.
(b) Specifications. Astaxanthin dimethyldisuccinate shall conform
to the following specifications and shall be free from impurities other
than those named to the extent that such impurities may be avoided by
good manufacturing practice:
(1) Physical state, solid.
(2) 0.05 percent solution in chloroform, complete and clear.
(3) Absorption maximum wavelength 484-493 nanometers (in
chloroform).
(4) Residue on ignition, not more than 0.1 percent.
(5) Total carotenoids other than astaxanthin dimethyldisuccinate,
not more than 4 percent.
(6) Lead, not more than 5 milligrams per kilogram (mg/kg) (5 parts
per million).
(7) Arsenic, not more than 2 mg/kg (2 parts per million).
(8) Mercury, not more than 1 mg/kg (1 part per million).
(9) Heavy metals, not more than 10 mg/kg (10 parts per million).
(10) Assay including astaxanthin dimethyldisuccinate, astaxanthin
monomethylsuccinate, and astaxanthin, minimum 96 percent.
(c) Uses and restrictions. Astaxanthin dimethyldisuccinate may be
safely used in the feed of salmonid fish in accordance with the
following prescribed conditions:
(1) The color additive is used to enhance the pink to orange-red
color of the flesh of salmonid fish.
(2) The quantity of astaxanthin dimethyldisuccinate in the finished
feed, when used alone or in combination with other astaxanthin color
additive sources listed in this part 73, shall not exceed 110
milligrams per kilogram (mg/kg), which is equivalent to 80 mg/kg
astaxanthin (72 grams per ton).
(d) Labeling requirements. (1) The labeling of the color additive
and any premixes prepared therefrom shall bear expiration dates for the
sealed and open container (established through generally accepted
stability testing methods), other information required by Sec. 70.25
of this chapter, and adequate directions to prepare a final product
complying with the limitations prescribed in paragraph (c) of this
section.
(2) The presence of the color additive in finished fish feed
prepared according to paragraph (c) of this section shall be declared
in accordance with Sec. 501.4 of this chapter.
(3) The presence of the color additive in salmonid fish that have
been fed feeds containing astaxanthin dimethyldisuccinate shall be
declared in accordance with Sec. Sec. 101.22(b), (c), and (k)(2), and
101.100(a)(2) of this chapter.
(e) Exemption from certification. Certification of this color
additive is not necessary for the protection of the public health, and
therefore batches thereof are exempt from the certification
requirements of section 721(c) of the act.
Dated: October 21, 2009.
Leslye M. Fraser,
Director, Office of Regulations, Policy and Social Sciences, Center for
Food Safety and Applied Nutrition.
[FR Doc. E9-26524 Filed 11-04-09; 8:45 am]
BILLING CODE 4160-01-S